Jason Krentz
About Jason Krentz
Jason Krentz serves as the Chief Product Supply Officer at Asklepios BioPharmaceutical, Inc., bringing extensive experience in manufacturing and technical operations from previous roles in various pharmaceutical companies. He holds a BS in Materials Science Engineering from the University of Michigan and an MBA from Saint Joseph's University.
Work at Asklepios BioPharmaceutical
Jason Krentz serves as the Chief Product Supply Officer at Asklepios BioPharmaceutical, Inc. (AskBio) since 2022. In this role, he is responsible for overseeing product supply strategies and operations within the organization. His leadership contributes to the company's mission of advancing gene therapies and biopharmaceuticals. AskBio is based in Philadelphia, Pennsylvania, and focuses on innovative approaches to treat various diseases.
Education and Expertise
Jason Krentz holds a Bachelor of Science degree in Materials Science Engineering from the University of Michigan, which he completed from 1990 to 1994. He furthered his education by obtaining a Master of Business Administration (MBA) from Saint Joseph's University - Erivan K. Haub School of Business, studying from 2003 to 2007. His educational background equips him with a strong foundation in both engineering and business management.
Background
Before his current role, Jason Krentz accumulated extensive experience in the biopharmaceutical industry. He began his career as a Naval Officer in the US Navy, serving from 1994 to 2000. He transitioned into the pharmaceutical sector, holding various positions including Executive Director of Technical Operations at Tengion, and Vice President of Manufacturing Operations at Endo Pharmaceuticals. His diverse background spans multiple roles in technical operations and supply chain management.
Previous Roles and Responsibilities
Jason Krentz has held several significant positions in the biopharmaceutical industry. He served as Chief Technology Officer at Tmunity Therapeutics Incorporated from 2018 to 2022, where he focused on advancing therapeutic technologies. Prior to that, he was Vice President of Technical Operations at Auxilium Pharmaceuticals from 2011 to 2015, and Associate Director of Cell Culture Operations at Centocor from 2002 to 2007. His career reflects a strong commitment to operational excellence and innovation.